Search

everythinglearnresearchcommunity

for

Search:↓

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

New alopecia treatments aim for better results and fewer side effects.

New hair products are being developed to keep hair and scalp healthy for everyone.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

Hair follicles are valuable for regenerative medicine and wound healing.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Using neurohormones to control keratin can lead to new skin disease treatments.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Epidermal stem cells have potential for personalized regenerative medicine but need careful handling to avoid cancer.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Different body parts have varying levels of certain hair follicle markers.

Hair follicle regeneration is possible but challenging, especially in humans, due to the need for specific cells and a better understanding of how they signal growth.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.